Sector Alpha Week of 2026-07-29
Sector Alpha — machine-written from the numbers · Data as of 2026-07-29

AirSculpt Technologies, Inc.

AIRS
Healthcare · Medical Care Facilities

AirSculpt Technologies, Inc.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.

Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk.

The price is between stages. Underneath, the last four quarters read mixed. What settles it: the next one or two quarters of delivery.

Price
$4.7
−28.0% 1Y
Revenue (Mar 26)
$0.0 B
+0.0% YoY
Profit (Mar 26)
$0.0 B
Operating margin
0.0%
flat YoY
ROE
−13%
FY25
ROIC
−3.2%
vs WACC 15.3% → −18.5 pp
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

AirSculpt Technologies, Inc. trades at $4.7, between stages. That is +13.9% against its own 200-day average. It sits at 31% of a 52-week range of $2 to $11. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 14 straight weeks.

Today the stock is between stages. At $4.7 it trades +13.9% versus its 200-day average and sits at 31% of its 52-week range ($2–$11).

Jul 26: $4.7 Weekly closing price ($) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 1-year window.
+13.9% versus the 200-day line, week — of stage —
Price50-day avg200-day avg
$12.2$9.3$6.5$3.6$0.8$$5$4Jul 25Oct 25Jan 26Apr 26Jul 26
$12.2$9.3$6.5$3.6$0.8$$5$4Jul 25Jan 26Jul 26
Beating or trailing, week by week since 2025 Each cell is one week from 2025 to now (56 weeks): the stock's trailing 13-week return minus the S&P 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the S&P 500 reading is not held.
trailing 13-week return vs the S&P 500
Jul 25Jul 26

Against the market, two honest reads. Cumulative: over the last 1.0 years the stock moved −6% while the S&P 500 moved +19% — behind the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 14 straight weeks — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

→ The trend is one thing; the bill is another. Are you paying up for it? Next: how the P/E reads against its own history.

02 · Valuation

Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.

P/E does not price AirSculpt Technologies, Inc. — earnings are negative, so there is no multiple to rank against its own history. The revenue and margin lines below are where a turn, when it comes, would show first. A P/E returns here the first period the bottom line turns positive.

With earnings negative, P/E does not price — there is no multiple to rank against its own history. The revenue and margin lines below are where the turn, when it comes, will show first.

P/E
earnings negative
PEG
n/m
not derivable — 3-year earnings growth unavailable

Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.

→ Cheap or dear rides on the earnings. Are they actually growing? Next: the fundamental stage — where the business sits in its arc, and how growth has compounded.

03 · Stage: No read

Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

AirSculpt Technologies, Inc. reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 12 quarters across 2 curves, on partial evidence.

Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. Base-effect spikes shown pinned (▲). A missing point means that reading is not held for the quarter.
the trajectory the stage is read from
RevenueProfitEPS
27%−84%14%−142%0.6%−200%−13%−258%−26%−316%%%−17.6%−200%−300%Jun 23Sep 24Mar 26
27%−84%14%−142%0.6%−200%−13%−258%−26%−316%%%−17.6%−200%−300%Jun 23Sep 24Mar 26
ROCE Trailing-twelve-month operating profit (before interest and tax) as a share of average capital employed — total assets minus current liabilities, the standard textbook basis, %.
the return curve, computed quarterly
ROCE
12%7.3%2.4%−2.6%−7.5%%−6.1%Jun 23Sep 24Mar 26
12%7.3%2.4%−2.6%−7.5%%−6.1%Jun 23Sep 24Mar 26
Revenue growth
Recovering
latest −17.6% · span −22.2% to +23.5%
ROCE
Falling
latest −6.1% · span −6.1%–10.8%

Why it matters: with too little history, an honest page says so instead of guessing a trajectory.

Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.

Growth, year by year: revenue −16.7% in FY25, profit null Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn.
Revenue YoYProfit YoY
35%−198.8%21%−199.4%7.1%−200.0%−6.7%−200.6%−21%−201.2%%%−16.7%−200%FY21FY23FY25
35%−198.8%21%−199.4%7.1%−200.0%−6.7%−200.6%−21%−201.2%%%−16.7%−200%FY21FY23FY25
TTM growth by quarter Trailing-twelve-month growth versus the year-ago TTM, per quarter, %: revenue (left axis); profit and EPS (right axis). The acceleration read compares the last 4 quarters (−17.6%) with the last 8 annualized (−18.4%). Spikes shown pinned (▲).
revenue stabilising
Revenue TTM YoYProfit TTM YoYEPS TTM YoY
27%−84%14%−142%0.6%−200%−13%−258%−26%−316%%%−17.6%−200%Jun 23Sep 24Mar 26
27%−84%14%−142%0.6%−200%−13%−258%−26%−316%%%−17.6%−200%Jun 23Sep 24Mar 26
Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; stock price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue−16.7%−4.1%
Stock price−28.0%
Revenue YoY (Mar 26)
+0.0%
latest quarter vs a year ago
Revenue 10y
3.6%
long-run compound pace

→ The stage names the trajectory. Next: the revenue line that produces it, quarter by quarter.

04 · 4-Factor Sector Score

4-Factor Sector Score

No sector-relative score — AirSculpt Technologies, Inc. is not among the largest members shown in this industry comparison for Medical Care Facilities.

The score is a rank WITHIN a peer set: every metric is scored by percentile against the other members. Without the peer set there is no score to state, so none is invented here.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

AirSculpt Technologies, Inc. reported $0.0 B of revenue in the Mar 26 quarter, +0.0% year on year. Over 4 years it has compounded at 3.6% a year. The last full year, FY25, came in at $0.1 B. The last four reported quarters add to $0.1 B.

AirSculpt Technologies, Inc. reported $0.0 B of revenue in the Mar 26 quarter, +0.0% year on year. Over 4 years it has compounded at 3.6% a year. The last full year, FY25, came in at $0.1 B. The last four reported quarters add to $0.1 B.

FY25 revenue came in at $0.1 B (−16.7% on the year), capping 4 years at 3.6% compound. The latest quarter (Mar 26) printed $0.0 B, +0.0% year on year.

FY25 revenue $0.1 B (−16.7% YoY) Revenue bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
3.6% a year over 4 years
RevenueYoY growth
0.2235%0.1621%0.117.1%0.05−6.7%0.00−21%$ B%$0B−16.7%FY21FY23FY25
0.2235%0.1621%0.117.1%0.05−6.7%0.00−21%$ B%$0B−16.7%FY21FY23FY25
Mar 26: $0.0 B (+0.0% YoY) Quarterly revenue bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Revenue (quarterly)YoY growth
0.0629%0.0515%0.030.0%0.02−15%0.00−29%$ B%$0B0%Jun 23Sep 24Mar 26
0.0629%0.0515%0.030.0%0.02−15%0.00−29%$ B%$0B0%Jun 23Sep 24Mar 26

Pace check: the last four quarters averaged −17.5% growth against the decade's 3.6% — the current year is running slower than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew −17.6% over the last 4 quarters against −18.4%/yr over the last 8 — stabilising.

→ Revenue grew — did margins hold as it scaled? Next: 0.0% this quarter (+0.0 pp YoY).

06 · Operating margin

Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

AirSculpt Technologies, Inc.'s operating margin is 0.0% in the Mar 26 quarter, +0.0 percentage points against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −6.7% to 15.4%. The current quarter sits inside that band.

AirSculpt Technologies, Inc.'s operating margin is 0.0% in the Mar 26 quarter, +0.0 percentage points against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −6.7% to 15.4%. The current quarter sits inside that band.

The latest quarter's operating margin is 0.0%, +0.0 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −6.7%–15.4%.

Why the margin moved: operating margin went +0.0 pp year on year while gross margin went +0.0 pp — the gain came mostly from the gross line: input costs and pricing.

FY25: −6.7% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 5-year window.
within a −6.7–15.4% band over 5 years
operating marginYoY change (pp)
17%6.6%11%0.7%4.3%−5.2%−2.1%−11%−8.5%−17%%%−6.7%−6.7%FY21FY23FY25
17%6.6%11%0.7%4.3%−5.2%−2.1%−11%−8.5%−17%%%−6.7%−6.7%FY21FY23FY25
Mar 26: 0.0% operating margin (+0.0 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
24%30%8.8%13%−6.7%−4.1%−22%−21%−38%−38%%%0%0%Jun 23Sep 24Mar 26
24%30%8.8%13%−6.7%−4.1%−22%−21%−38%−38%%%0%0%Jun 23Sep 24Mar 26

→ Margins held — did that reach the bottom line? Next: profit null in the latest quarter.

07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

AirSculpt Technologies, Inc. earned $0.0 B of net profit in the Mar 26 quarter. The full FY25 year was a loss of $0.01 B. That is 0.0% of the quarter's revenue. The same quarter a year earlier earned $0.0 B. 2 of the last 12 reported quarters were loss-making.

AirSculpt Technologies, Inc. earned $0.0 B of net profit in the Mar 26 quarter. The full FY25 year was a loss of $0.01 B. That is 0.0% of the quarter's revenue. The same quarter a year earlier earned $0.0 B. 2 of the last 12 reported quarters were loss-making.

Mar 26 profit was $0.0 B, null year on year. On the full year, FY25 printed $−0.0 B (null).

FY25 profit $−0.0 B (null YoY) Net profit bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
Net profitYoY growth
0.012−198.8%0.006−199.4%0.000−200.0%−0.006−200.6%−0.012−201.2%$ B%$0B−200%FY21FY23FY25
0.012−198.8%0.006−199.4%0.000−200.0%−0.006−200.6%−0.012−201.2%$ B%$0B−200%FY21FY23FY25
Mar 26: $0.0 B (null YoY) Quarterly net profit bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Net profit (quarterly)YoY growth
0.012−98.8%0.006−99.4%0.000−100.0%−0.006−100.6%−0.012−101.2%$ B%$0B−100%Jun 23Sep 24Mar 26
0.012−98.8%0.006−99.4%0.000−100.0%−0.006−100.6%−0.012−101.2%$ B%$0B−100%Jun 23Sep 24Mar 26

→ Profit rose — but did the cash follow?

08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

AirSculpt Technologies, Inc.'s cash-flow history is too thin to judge how much reported profit converts into cash. In FY25 that was $0.0 B of operating cash against $−0.0 B of profit. After $0.0 B of capital spending, $0.0 B was left as free cash. Cash resolution here is annual, because quarterly cash statements are not published.

FY25: operating cash of $0.0 B against reported profit of $−0.0 B, leaving free cash of $0.0 B after $0.0 B of capital spending.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY25: CFO $0.0 B vs profit $−0.0 B Operating cash flow and net profit by fiscal year, $ B; the line is free cash flow (CFO minus capital spending). 5-year window, annual resolution.
Operating cashNet profitFree cash
0.030.020.010.00−0.01$ B$0B$0B$0BFY21FY23FY25
0.030.020.010.00−0.01$ B$0B$0B$0BFY21FY23FY25
Mar 26: operating cash $0.0 B Operating cash per quarter, $ B (bars); conversion = operating cash as % of net profit (line, right). Last 12 quarters. Dashed line = 100%.
Operating cash (quarterly)Conversion100%
0.011108%0.00879%0.00550%0.00321%0.000−8.0%$ B%$0B0%Jun 23Sep 24Mar 26
0.011108%0.00879%0.00550%0.00321%0.000−8.0%$ B%$0B0%Jun 23Sep 24Mar 26

Router verdict: the visible cash user is investment — the next section checks what the spending is buying.

→ So follow the cash to where it goes. Next: $0.0 B of building over 3 years.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

AirSculpt Technologies, Inc. does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $0.0 B over the last 3 years. Averaged over those years that is 0.0% of FY25 revenue a year.

Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.

On the investment side: capital spending of $0.0 B over the last 3 fiscal years.

FY25: capex $0.0 B Capital spending per fiscal year, $ B (bars).
steady investment
Capex
0.0110.0080.0050.0030.000$ B$0BFY21FY23FY25
0.0110.0080.0050.0030.000$ B$0BFY21FY23FY25
Mar 26: capex $0.0 B in the quarter Capital spending per quarter, $ B (bars, left); free cash flow, $ B (line, right). Last 12 quarters.
Capex (quarterly)Free cash
1.20.0110.60.0080.00.005−0.60.002−1.2−0.001$ B$ B$0B$0BJun 23Sep 24Mar 26
1.20.0110.60.0080.00.005−0.60.002−1.2−0.001$ B$ B$0B$0BJun 23Sep 24Mar 26

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

→ Does all this activity actually earn its cost of capital? Next: ROE is −13% and the ROIC − WACC spread is −18.5 pp.

10 · Return on equity

Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.

AirSculpt Technologies, Inc. earns a ROE of −11% in FY25. That is up from a trough of −14% in FY22. Return on invested capital clears the cost of that capital by −18.5 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is −6.7% net margin on 0.79× asset turns.

FY25 ROE is −11%, recovered from a FY22 trough of −14% — the full ladder below shows the fall and the climb, undoctored.

🚨 Why the return is what it is — the wiring (FY25): −6.7% net margin × 0.79× asset turns × 2.11× balance-sheet leverage ≈ −11.2% on equity. Margin does its share; leverage is a meaningful part of the equation.

The capstone test — ROIC − WACC: −3.2% − 15.3% = a −18.5 pp spread. The 15.3% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.

FY25: ROE −11% Return on equity by fiscal year, % (line); ROIC by fiscal year, % (line). 5-year window, dips included. Dashed line = the 15.3% cost of capital used on this page.
the climb back from FY22's −14%
ROEROIC (annual)WACC
18%9.1%0.5%−8.1%−17%%−11.1%−4.5%FY21FY23FY25
18%9.1%0.5%−8.1%−17%%−11.1%−4.5%FY21FY23FY25
Mar 26: ROIC −5.4% (TTM) vs WACC 15.3% Trailing-twelve-month ROIC and ROE, per quarter, %; dashed line = the cost of capital. Last 12 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROIC (TTM)ROE (TTM)WACC
18%7.5%−3.2%−14%−25%%−5.4%−13.5%Jun 23Sep 24Mar 26
18%7.5%−3.2%−14%−25%%−5.4%−13.5%Jun 23Sep 24Mar 26

→ Returns like these — is the balance sheet borrowing to make them? Next: debt-to-equity is 0.71.

11 · Dividend

Dividend

AirSculpt Technologies, Inc. pays no dividend. Across the last 12 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.

AirSculpt Technologies, Inc. does not currently pay a dividend. Across the last 12 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.

→ No payout to follow. The cash question becomes what the business does with what it earns instead.

12 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

AirSculpt Technologies, Inc. carries total debt of $0.1 B against shareholder equity of $0.1 B as of Mar 26, a debt-to-equity of 0.70. On the annual view that ratio went from 1.25 in FY21 to 0.89 in FY25. Read the returns elsewhere on this page with that leverage in mind.

Mar 26: total debt of $0.1 B against shareholder equity of $0.1 B — a debt-to-equity of 0.70. On the annual view, debt-to-equity went from 1.25 (FY21) to 0.89 (FY25). Read the returns on this page with that leverage in mind.

FY25: debt $0.1 B at 0.89× equity Total debt by fiscal year, $ B (bars); debt-to-equity, × (line). 5-year window.
Total debtDebt-to-equity
0.121.6×0.091.4×0.061.2×0.031.0×0.000.8×$ B×$0B0.89×FY21FY23FY25
0.121.6×0.091.4×0.061.2×0.031.0×0.000.8×$ B×$0B0.89×FY21FY23FY25
Mar 26: debt $0.1 B, debt-to-equity 0.70 Total debt per quarter, $ B (bars); debt-to-equity, × (line). Last 12 quarters.
Total debt (quarterly)Debt-to-equity
0.121.4×0.091.2×0.061.0×0.030.8×0.000.6×$ B×$0B0.70×Jun 23Sep 24Mar 26
0.121.4×0.091.2×0.061.0×0.030.8×0.000.6×$ B×$0B0.70×Jun 23Sep 24Mar 26

→ Who owns this, and are they adding or leaving? Next: short interest is 20.7% of the float.

13 · Ownership

Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.

20.7% of AirSculpt Technologies, Inc.'s tradable float is currently sold short — a large bloc is positioned against it. At typical trading volumes those positions would take about 6.2 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.

The latest reading: 20.7% of the float is sold short, and at typical trading volumes it would take about 6.2 days to buy those positions back. A large bloc is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.

Short interest
20.7%
of the tradable float
Days to cover
6.2
at typical volumes

Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.

→ One last check: does the safety math agree? Next: the balance-sheet safety line.

14 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

AirSculpt Technologies, Inc.: the Z-score reads 2.18. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits in the grey band between the two. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.

Why it matters: a Z-score of 2.18 sits in the grey band — neither clearly safe nor clearly distressed.

The safety line in one sentence: the Z-score reads 2.18.

Related companies · same industry · Medical Care Facilities Every company is compared on the shape of its own curves, not static ratios. The Revenue, EPS and ROCE columns each draw that company's last 12 quarters as a mini line of the ACTUAL level (trailing-twelve-month revenue and EPS, and the ROCE itself) — so a line that climbs is a business getting bigger, a line that sinks is one shrinking. The colour tracks the same line: green when it is rising or steadily healthy, amber when it is rolling over from a high (still elevated but turning down), red when it is falling, grey when flat or stuck. Colour and direction always agree — a green line never points down. The ROCE curve is the return on capital (annual readings for peers, so a slightly coarser line than the quarterly one at the top of this page). The Stage column then runs the same 12-quarter trajectory classifier used at the top of the page on each company and names where it sits. What lands a company in each bucket: CONSISTENT — growth stays positive across the window and returns are healthy (ROCE ≥ 15%, or ROE ≥ 12% for lenders); IMPROVING — profit or EPS fell into real decline, bottomed a few quarters back, and has climbed back to positive and held there; TURNING AROUND — the same kind of trough but more recent, with the latest quarters just lifting off it (an early, unconfirmed turn); TOPPING OUT — growth is still positive but decelerating hard from its own peak while returns have stopped rising; DETERIORATING — two or more growth curves are shrinking (latest below zero) and staying there, not one soft quarter; MIXED — the curves genuinely disagree, or no clean majority, so no single word fits; NO READ — fewer than eight usable quarters. It is a like-for-like read of every company against its own past, not a ranking against the group.
CompanyP/EMkt capRevenueEPSROCEStage
AirSculpt Technologies, Inc. this page$0BNo read
HCA Healthcare, Inc.14.0×$93BImproving
Tenet Healthcare Corporation10.2×$23BMixed
DaVita Inc.23.0×$15BConsistent
Fresenius Medical Care AG12.0×$13BMixed
Encompass Health Corporation19.4×$12BMixed
The Ensign Group, Inc.28.7×$11BConsistent
Universal Health Services, Inc.6.8×$10BMixed
PACS Group, Inc.30.2×$7BImproving
Chemed Corporation26.0×$7BTopping out
LifeStance Health Group, Inc.192.4×$4BNo read
Concentra Group Holdings Parent, Inc.23.9×$4BTurning around
Brookdale Senior Living Inc.$4BNo read
National HealthCare Corporation29.3×$4BMixed
Option Care Health, Inc.17.5×$4BImproving
Acadia Healthcare Company, Inc.$3BDeteriorating
Guardian Pharmacy Services, Inc.50.1×$3BMixed
Addus HomeCare Corporation22.0×$2BMixed
Pediatrix Medical Group, Inc.13.0×$2BImproving
Aveanna Healthcare Holdings Inc.8.3×$2BNo read
Select Medical Holdings Corporation15.4×$2BImproving
Surgery Partners, Inc.$2BMixed
Sonida Senior Living, Inc.$2BNo read
Astrana Health, Inc.62.3×$2BTurning around
agilon health, inc.$2BNo read
Ardent Health, Inc.12.1×$2BDeteriorating
Healthcare Services Group, Inc.13.8×$2BTurning around
InnovAge Holding Corp.$2BNo read
COMPASS Pathways plc$1B
The Pennant Group, Inc.48.8×$1BMixed
AMN Healthcare Services, Inc.$1BDeteriorating
U.S. Physical Therapy, Inc.156.4×$1BMixed
Nutex Health Inc.10.8×$1BNo read
GMR Solutions Inc.7.5×$1B
Charming Medical Limited767.2×$1B
The Oncology Institute, Inc.$0BNo read
Strata Critical Medical, Inc.9.4×$0BNo read
Cross Country Healthcare, Inc.$0BDeteriorating
Auna S.A.19.5×$0BNo read
Community Health Systems, Inc.1.5×$0BTurning around
12 · Frequently asked questions

Frequently asked questions

What is AirSculpt Technologies, Inc.'s stock price today?

AirSculpt Technologies, Inc. trades at $4.7, −28.0% over the past year. The company is valued at $0.0 B. The stock sits at 31% of its 52-week range of $2–$11, +13.9% versus its 200-day average. Against the S&P 500 it has been ahead on a trailing-13-week view for 14 weeks. — as of 29 July 2026.

What were AirSculpt Technologies, Inc.'s latest quarterly results?

AirSculpt Technologies, Inc. reported revenue of $0.0 B and net profit of $0.0 B for the Mar 26 quarter. The operating margin was 0.0%, 0.0 pp higher than a year earlier. — as of 29 July 2026.

What is AirSculpt Technologies, Inc.'s revenue?

AirSculpt Technologies, Inc. reported revenue of $0.0 B in the Mar 26 quarter, +0.0% year on year. For the full FY25 fiscal year, revenue was $0.1 B (−16.7%). Over the last 4 years revenue compounded at 3.6% a year. — as of 29 July 2026.

What is AirSculpt Technologies, Inc.'s profit?

AirSculpt Technologies, Inc. earned $0.0 B of net profit in the Mar 26 quarter. Full-year FY25 profit was $−0.0 B. The operating margin ran 0.0% in the latest quarter. — as of 29 July 2026.

What is AirSculpt Technologies, Inc.'s market cap?

AirSculpt Technologies, Inc.'s market capitalisation is $0.0 B at a stock price of $4.7. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 29 July 2026.

Does AirSculpt Technologies, Inc. pay a dividend?

No — AirSculpt Technologies, Inc. has declared no dividend per share in any of its last 12 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 29 July 2026.

How is AirSculpt Technologies, Inc. performing?

AirSculpt Technologies, Inc.'s latest readings are below. Against the S&P 500 it has been ahead on a trailing-13-week view for 14 weeks. This describes what the data did, not a rating. — as of 29 July 2026.

Is AirSculpt Technologies, Inc. beating the market?

On recent form, yes — AirSculpt Technologies, Inc. has been ahead of the S&P 500 on a trailing-13-week view for 14 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 1.0 years the stock moved −6% against the S&P 500's +19% — behind the index over the full window. — as of 29 July 2026.

Will AirSculpt Technologies, Inc.'s stock price go up?

This page publishes no price forecast for AirSculpt Technologies, Inc. What it measures instead: the stock price is $4.7. Direction is not something this site claims to know. — as of 29 July 2026.

Is the market betting against AirSculpt Technologies, Inc.?

Yes — short interest is 20.7% of AirSculpt Technologies, Inc.'s tradable float, about 6.2 days to cover at typical volumes. A crowded short: a large bloc is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 29 July 2026.

Does AirSculpt Technologies, Inc. have too much debt?

It is moderate — AirSculpt Technologies, Inc.'s debt-to-equity is 0.71. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 29 July 2026.

What is AirSculpt Technologies, Inc.'s capex?

AirSculpt Technologies, Inc. spent $0.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.0 B. — as of 29 July 2026.

What is AirSculpt Technologies, Inc.'s cash flow?

AirSculpt Technologies, Inc. generated $0.0 B of operating cash flow in FY25 and $0.0 B of free cash flow after $0.0 B of capital spending. Reported profit that year was $−0.0 B, so operating cash ran ahead of profit. — as of 29 July 2026.

How financially safe is AirSculpt Technologies, Inc.?

On the balance sheet, the Z-score reads 2.18 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That is in the grey band — neither clearly safe nor clearly distressed. — as of 29 July 2026.

Where is AirSculpt Technologies, Inc. in its business cycle?

AirSculpt Technologies, Inc.'s FY25 operating margin was −6.7%, against a 5-year band of −6.7%–15.4%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 0.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 29 July 2026.

What could break the AirSculpt Technologies, Inc. story?

Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 29 July 2026.

Is AirSculpt Technologies, Inc. a stock worth studying right now?

This is not investment advice. The machine read: AirSculpt Technologies, Inc.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 29 July 2026.

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI